Science Daily

New drug may reduce need for aortic valve surgeries by slowing disease progression

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
Reuters

Medtronic valve for heart defects works well a year later-study

WASHINGTON (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow ...
Zawya

Medtronic valve for congenital heart defects works well a year later - study

WASHINGTON, March 30 (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year ...
Zawya

UPDATE 1-Medtronic valve for heart defects works well a year later-study

WASHINGTON, March 30 (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year ...
Medindia

New Drug for Aortic Valve Stenosis May Slow Disease Progression and Delay Surgery

Aortic valve stenosis (AVS) is a major health issue, impacting over 1.5 million Americans and millions more worldwide. Researchers at the Mayo Clinic are investigating a new drug, ataciguat, for ...
Mid Day

Heart repair without surgery: The TEER procedure

Transcatheter Edge-to-Edge Repair (TEER) is a minimally invasive treatment option for high-risk patients with Mitral Valve Leakage. TEER has proven to be the most advanced treatment option for ...
The Hindu

Heart repair without surgery: The TEER procedure

Mitral Valve Leakage, also known as mitral regurgitation, is a symptomatic, cardiovascular condition wherein the mitral valve does not close tightly. This causes blood to flow backwards into the left ...